When the European Union enacted the lengthy and complex law known as Mifid II in January this year, the extent of the new regulation’s global reach was unclear. Nearly a year later, one of many effects advisers and other financial professionals have had to adjust to is the accelerated upheaval of the investment research market.
“While research aggregation has been around in various forms for many years, the Nucleus195 end-to-end ecosystem is a revolutionary idea that we developed last year. There are no other platforms that address every aspect of the research process like Nucleus195”
The exodus of senior analysts from some of these brokers will continue to grow in the next 12-18 months, according to Mehdi Sunderji, co-founder of American-based research platform Nucleus 195.
“With most asset managers absorbing research costs within their own P&L’s there is still a push to further cut the number of research counter-parties they engage with – leaving them, in most cases, with access to just the larger research providers but cut off from the smaller players.”
“There’s no doubt that the industry is going through a sea-change, and our presence on the Nucleus195 platform ensures our analysts’ research will be accessible to any investor who seeks it out,” says Gary Esayian, CEO of BCS Global Markets
“Our platform allows investors to find and purchase the research they need in markets where they want to invest with transparent pricing and technological efficiency,” says Scott Duxbury, who co-founded Nucleus195 with Mehdi Sunderji and Doug Rivelli.
AlphaWeek’s Greg Winterton sat down with co-founder Mehdi Sunderji to discuss trends in the research consumption industry.
Research drives the bus. But who’s in charge of the research? Or managing it? That’s a job being looked at by Stamford, Connecticut-based Nucleus195, a new firm founded in part by Wall Street alum Doug Rivelli.